Literature DB >> 25326116

Predictive Factors for Endoscopic Visibility and Strategies for Pre-endoscopic Prokinetics Use in Patients with Upper Gastrointestinal Bleeding.

Jun Uk Lim1, Jae Jun Park, Young Hoon Youn, Sunyong Kim, Jung Won Jeon, Sung Won Jung, Hyun Phil Shin, Jae Myung Cha, Kwang Ro Joo, Joung Il Lee.   

Abstract

BACKGROUND: Although current guideline recommends selective use of pre-endoscopic prokinetics to increase diagnostic yield in upper gastrointestinal bleeding (UGIB) patients, no data to guide the use of these drugs are available. AIMS: We aimed to investigate predictive factors for endoscopic visibility and develop simple and useful strategies for pre-endoscopic prokinetics use in UGIB patients.
METHODS: A total of 220 consecutive patients who underwent upper endoscopy for suspicious UGIB were enrolled. Patients were randomly allocated to either a training or a validation set at a 2:1 ratio. Significant parameters on univariate analysis were subsequently tested by a classification and regression tree (CART) analysis.
RESULTS: Time to endoscopy and nasogastric aspirate findings were independently related to endoscopic visibility. The CART analysis generated algorithms proposed sequential use of time to endoscopy (≤5.2 vs. >5.2 h) and nasogastric aspirate findings (red blood or coffee rounds vs. clear aspirate) for predicting endoscopic visibility. Prediction of unacceptable visibility in the validation set produced sensitivity, specificity, positive predictive value, and negative predictive value of 75.8, 67.5, 65.8, and 77.1 %, respectively. Accurate prediction for visibility was identified in 52 of 73 patients (71.2 %).
CONCLUSIONS: Time to endoscopy and nasogastric aspirate findings were independently related to endoscopic visibility in patients with UGIB. A decision-tree model incorporating these two variables may be useful for selecting UGIB patients who benefit from pre-endoscopic prokinetics use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25326116     DOI: 10.1007/s10620-014-3393-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

Review 1.  The overall approach to the management of upper gastrointestinal bleeding.

Authors:  Vipul Jairath; Alan N Barkun
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-10

Review 2.  Management of upper gastrointestinal bleeding in the patient with chronic liver disease.

Authors:  R Jutabha; D M Jensen
Journal:  Med Clin North Am       Date:  1996-09       Impact factor: 5.456

3.  Characterizing exposure-disease association in human populations using the Lorenz curve and Gini index.

Authors:  W C Lee
Journal:  Stat Med       Date:  1997-04-15       Impact factor: 2.373

4.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

5.  Early indicators of prognosis in upper gastrointestinal hemorrhage.

Authors:  D A Corley; A M Stefan; M Wolf; E F Cook; T H Lee
Journal:  Am J Gastroenterol       Date:  1998-03       Impact factor: 10.864

6.  The uncleared fundal pool in acute upper gastrointestinal bleeding: implications and outcomes.

Authors:  N H Stollman; R V Putcha; B R Neustater; M Tagle; J B Raskin; A I Rogers
Journal:  Gastrointest Endosc       Date:  1997-10       Impact factor: 9.427

7.  Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial.

Authors:  Dominique Pateron; Eric Vicaut; Erwan Debuc; Karima Sahraoui; Nicolas Carbonell; Xavier Bobbia; Dominique Thabut; Frédéric Adnet; Pierre Nahon; Rolland Amathieu; Mounir Aout; Nicolas Javaud; Patrick Ray; Jean Claude Trinchet
Journal:  Ann Emerg Med       Date:  2011-02-17       Impact factor: 5.721

8.  A randomized controlled trial of gastric lavage prior to endoscopy for acute upper gastrointestinal bleeding.

Authors:  Scott D Lee; David J Kearney
Journal:  J Clin Gastroenterol       Date:  2004 Nov-Dec       Impact factor: 3.062

9.  International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

10.  Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study.

Authors:  Benoit Coffin; Marc Pocard; Yves Panis; Florence Riche; Marie-Jo Lainé; Alain Bitoun; Marc Lémann; Yoram Bouhnik; Patrice Valleur
Journal:  Gastrointest Endosc       Date:  2002-08       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.